MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 8 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Comparative Study | 4 | 0.0 |
*Genes, Tumor Suppressor | 15 | 1.0 |
Humans | 48 | 0.0 |
Loss of Heterozygosity | 5 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Mutation | 6 | 0.0 |
Polymorphism, Single-Stranded Conformational | 8 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Proteins/*genetics/metabolism | 8 | 3.0 |
Research Support, Non-U.S. Gov't | 41 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Animals | 18 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cell Line | 8 | 0.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Protein Binding | 3 | 0.0 |
*Protein Biosynthesis | 4 | 0.0 |
Protein p53/metabolism | 5 | 0.0 |
Proteins/genetics | 3 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Thymidine/metabolism | 2 | 0.0 |
Tissue Distribution | 4 | 0.0 |
Tumor Cells, Cultured | 14 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Mice | 13 | 0.0 |
Proteins/genetics/*physiology | 3 | 2.0 |
Adolescent | 2 | 0.0 |
Adult | 7 | 0.0 |
Aged | 6 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Female | 12 | 0.0 |
Male | 8 | 0.0 |
Middle Aged | 8 | 0.0 |
Proteins/*metabolism | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Multigene Family | 2 | 0.0 |
Apoptosis/*physiology | 2 | 0.0 |
Fibroblasts/cytology | 2 | 0.0 |
Gene Expression | 4 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Ultraviolet Rays | 5 | 0.0 |
Alternative Splicing | 4 | 0.0 |
Apoptosis | 2 | 0.0 |
Base Sequence | 7 | 0.0 |
Cell Division | 3 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Gene Library | 3 | 0.0 |
Genes, Tumor Suppressor | 3 | 0.0 |
Protein Isoforms | 5 | 0.0 |
Signal Transduction | 2 | 0.0 |
*Tumor Suppressor Proteins | 3 | 0.0 |
Acetylation | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 7 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Genes, Tumor Suppressor/*physiology | 2 | 1.0 |
Growth Inhibitors/*genetics/metabolism | 2 | 40.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
DNA Damage | 2 | 0.0 |
Gene Expression/radiation effects | 2 | 10.0 |
Protein p53/physiology | 2 | 2.0 |
Proteins/genetics/metabolism/*physiology | 3 | 8.0 |
Transfection | 9 | 0.0 |
Mutation, Missense | 3 | 0.0 |
Protein Biosynthesis | 4 | 0.0 |
Proteins/*genetics | 12 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Fibroblasts | 2 | 0.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Carcinoma, Squamous Cell/*genetics | 2 | 1.0 |
DNA Primers/genetics | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
RNA, Messenger/*genetics | 2 | 0.0 |
*Transcription, Genetic | 3 | 0.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
Genes, Tumor Suppressor/*genetics | 3 | 0.0 |
*Membrane Proteins | 2 | 0.0 |
Mutation/*genetics | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Protein p53/*physiology | 2 | 1.0 |
In Situ Hybridization | 2 | 0.0 |
Cell Line, Tumor | 5 | 0.0 |
English Abstract | 3 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Cell Division/*physiology | 2 | 1.0 |
Cyclins/genetics | 2 | 1.0 |
Growth Inhibitors/genetics/*physiology | 2 | 33.0 |
Rats | 2 | 0.0 |
Growth Inhibitors/*genetics | 2 | 4.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Cell Cycle | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Proteins/*physiology | 3 | 1.0 |
Brain Neoplasms/*genetics | 2 | 1.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Exons | 3 | 0.0 |
*Mutation | 2 | 0.0 |
RNA, Neoplasm/genetics | 2 | 0.0 |
Protein p53/biosynthesis | 2 | 1.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
*Proto-Oncogene Proteins c-bcl-2 | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/*physiology | 2 | 1.0 |
Proteins/*genetics/*metabolism | 3 | 4.0 |
